The conventional paradigm of nonalcoholic fatty liver disease representing the “hepatic
manifestation of the metabolic syndrome” is outdated. We identified and summarized …

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world.
Presentation of the disease ranges from simple steatosis to non-alcoholic steatohepatitis …

Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …

Background and objective Fatty liver disease (FLD) is a common clinical complication; it is
associated with high morbidity and mortality. However, an early prediction of FLD patients …

Background & Aims: Nonalcoholic steatohepatitis (NASH) is a liver disease that complicates
insulin-resistant states. This trial tested the efficacy and safety of rosiglitazone, an insulin …

Nonalcoholic fatty liver disease (NAFLD) is consistently associated with features of the
metabolic syndrome, a condition carrying a high risk of cardiovascular events. We measured …

Obesity is the most prevalent health problem affecting all age groups, and leads to many
complications in the form of chronic heart disease, diabetes mellitus Type 2 and stroke. A …

Context In the last few years, several data have accumulated suggesting that obesity may be
associated with liver disease and disease progression. Accordingly, the worldwide epidemic …

High serum free fatty acid (FFA) levels are associated with metabolic syndrome (MS). This
study aimed to assess the association of fasting serum FFAs with nonalcoholic fatty liver …

Dandelion (Taraxacum officinale), an oriental herbal medicine, has been shown to favorably
affect choleretic, antirheumatic and diuretin properties. Recent reports have indicated that …